Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,900.00    0.00 (0.00%)
Bid:
1,900.00
Ask:
1,930.00
Spread: 30.00 (1.579%)
Market Cap: £230.86m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Director/PDMR Shareholding

3 Aug 2018 10:00

RNS Number : 6928W
S & U PLC
03 August 2018
 

 

03 August 2018

S & U plc ("S&U" or "the Company")

Director/PDMR Shareholding

 

The Company has today granted shadow share options in respect of 12,000 ordinary shares of 12.5p each in S & U to a Director of the Company under the Company's 2010 Long Term Incentive Plan ("LTIP"). 

 

These LTIP shadow share option awards were included in the Remuneration Policy and Annual Remuneration Report approved by shareholders at the Company's AGM in May 2018.

 

The earliest date the awards will vest is on 1 August 2021 all at an exercise price of 12.5p each. The vesting of the awards is subject to the Director remaining in employment with the Company until August 2020 and meeting specified performance targets.

 

The award is as follows:

Name of Director

 

Number of ordinary shares under shadow LTIP option

awarded

Total number of shares over which options or shadow options held under LTIP following notification

Number of ordinary shares owned outright

JG Thompson

12,000

102,000

Nil

 

 The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

John Guy Thompson

2

 

Reason for the notification

a)

 

Position/status

 

Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

S&U PLC

b)

 

LEI

213800QZ1X2A7J64SQ31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Shadow share options over Ordinary shares of 12.5p each

 

ISIN: GB0007655037

 

b)

 

Nature of the transaction

 

Grant of shadow share options in respect of 12,000 ordinary shares under the Company's 2010 Long Term Incentive Share Scheme

c)

 

Price(s) and volume(s)

 

 

Option Exercise Price(s)

Volume(s)

12.5p

12,000

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Option Exercise Price(s)

Volume(s)

12.5p

12,000

 

 

 

e)

 

Date of the transaction

 

3 August 2018

f)

 

Place of the transaction

Off market transaction

 

For further information, please contact:

S&U plc www.suplc.co.uk  

Enquiries:

Anthony Coombs

S&U plc

c/o Newgate Communications

Financial Public Relations

Bob Huxford, James Ash, Imogen Humphreys

Newgate Communications

020 7653 9848

SandUfpr@newgatecomms.com

 

Broker

Adrian Trimmings, Rishi Shah

Peel Hunt LLP

020 7418 8900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHELLFBVVFEBBD
Date   Source Headline
8th Feb 20137:00 amRNSTrading Statement
1st Feb 20134:00 pmRNSPurchase of Own Shares
6th Dec 20127:00 amRNSInterim Management Statement
1st Nov 20123:40 pmRNSDirector/PDMR Shareholding
4th Oct 20127:00 amRNSDirector/PDMR Shareholding
3rd Oct 201212:48 pmRNSDirector/PDMR Shareholding
26th Sep 20127:00 amRNSHalf Yearly Report
8th Aug 20127:00 amRNSTrading Statement
21st Jun 201210:07 amRNSDirector/PDMR Shareholding
13th Jun 20125:17 pmRNSDirector/PDMR Shareholding
29th May 20127:00 amRNSDTR 5.6.1 and Director/PDMR Shareholding
25th May 20125:15 pmRNSDirector/PDMR Shareholding - correction
25th May 20124:32 pmRNSDirector/PDMR Shareholding
24th May 201212:43 pmRNSAGM Statement
24th May 20127:00 amRNSInterim Management Statement
17th May 20124:14 pmRNSDirector/PDMR Shareholding
4th May 201211:07 amRNSDirector/PDMR Shareholding
17th Apr 20127:00 amRNSAnnual Financial Report
30th Mar 20122:48 pmRNSAnnual Information Update
29th Mar 20124:36 pmRNSFinal Results: Correction to dividend dates
29th Mar 20127:00 amRNSFinal Results
17th Feb 20127:00 amRNSTrading Statement
9th Dec 20117:00 amRNSInterim Management Statement
25th Nov 20117:00 amRNSDirector/PDMR Shareholding
3rd Nov 20118:57 amRNSDirector/PDMR Shareholding
3rd Oct 20114:32 pmRNSDirector/PDMR Shareholding
22nd Sep 20117:00 amRNSHalf Yearly Report
19th Aug 20113:23 pmRNSDirector/PDMR Shareholding
10th Aug 20117:00 amRNSTrading Statement
15th Jul 20114:32 pmRNSDirector/PDMR Shareholding
5th Jul 20114:52 pmRNSNotification of Major Interest in Shares
27th May 20117:00 amRNSDirector/PDMR Shareholding
13th May 201112:15 pmRNSAGM Statement and Consultation re Move to AIM
13th May 20117:00 amRNSInterim Management Statement
11th Apr 20117:00 amRNSAnnual Financial Report
8th Apr 20114:00 pmRNSDirector/PDMR Shareholding
1st Apr 20117:00 amRNSAnnual Information Update
30th Mar 20117:00 amRNSDirector/PDMR Shareholding
23rd Mar 20117:01 amRNSDirectorate Change
23rd Mar 20117:00 amRNSFinal Results
11th Feb 20117:00 amRNSTrading Statement
10th Dec 20107:00 amRNSInterim Management Statement
8th Oct 20101:30 pmRNSDirector/PDMR Shareholding
24th Sep 20104:41 pmRNSDirector/PDMR Shareholding
23rd Sep 20107:00 amRNSHalf Yearly Report
31st Aug 20107:01 amRNSChange of Adviser
11th Aug 20107:00 amRNSTrading Statement
18th Jun 20102:45 pmRNSDirector/PDMR Shareholding
4th Jun 20105:03 pmRNSDirector/PDMR Shareholding
24th May 20103:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.